Home NDC 59762-3070 azithromycin
Product NDC 59762-3070
11-digit product format 597623070
Labeler code 59762
Product ID 59762-3070_e65a0723-d06f-49f1-8af5-88f67338a90f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name azithromycin
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Greenstone LLC
Application NDA050784
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2002-05-24
Marketing end 0000-00-00
Substance AZITHROMYCIN DIHYDRATE
Active strength 500 mg/1
Pharmacologic classes Macrolide Antimicrobial [EPC],Macrolides [CS]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N050784-001 ZITHROMAX AZITHROMYCIN EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N050784-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded AZITHROMYCIN DIHYDRATE ACTIVE INGREDIENT 5FD1131I7S AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 AZITHROMYCIN ANHYDROUS ACTIVE MOIETY J2KLZ20U1M AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS INACTIVE INGREDIENT L11K75P92J AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 D&C RED NO. 30 INACTIVE INGREDIENT 2S42T2808B AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 LACTOSE INACTIVE INGREDIENT J2B2A4N98G AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 SODIUM PHOSPHATE, TRIBASIC, ANHYDROUS INACTIVE INGREDIENT SX01TZO3QZ AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 SUCROSE INACTIVE INGREDIENT C151H8M554 AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 15
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59762-3070 AZITHROMYCIN TABLET, FILM COATED AZITHROMYCIN POWDER, FOR SUSPENSION [GREENSTONE LLC] 41 Legacy NDC 20250416_f5b6daad-b5a9-462d-8e10-db22a7af1c72.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Zithromax AZITHROMYCIN DIHYDRATE Pfizer Laboratories Div Pfizer Inc db52b91e-79f7-4cc1-9564-f2eee8e31c45 2026-07-24 Warnings, Adverse reactions Exact identifier application applno (NDA): 050784 application number: NDA050784
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 59762-3070-1 59762307001 3 BLISTER PACK in 1 BOX (59762-3070-1) > 3 TABLET, FILM COATED in 1 BLISTER PACK 3 blister pack 2002-05-24 0000-00-00 No No Current